Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1553-1561

  Cai, Sumin ^a,d   He, Feng ^a,e   Samra, Hardeep S ^a,f   De La Maza, Luis M ^b   Bottazzi, Maria E ^c   Joshi, Sangeeta B ^a   Middaugh, C Russell ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d VaxInnate Corporation   (United States)

^e AMGEN INC   (United States)

^f MEDIMMUNE   (United States)

Author keywords

Biophysical characterization; Chlamydia; MOMP; Stabilization

Indexed keywords

ARGININE; BACTERIAL VACCINE; CHLAMYDIA VACCINE; CITRATE SODIUM; GUANIDINE; OUTER MEMBRANE PROTEIN; POLIDOCANOL; RECOMBINANT PROTEIN; SUCROSE; UNCLASSIFIED DRUG;

BACTERIAL OUTER MEMBRANE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; FLUORESCENCE SPECTROSCOPY; GENITAL TRACT INFECTION; LIGHT SCATTERING; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SEXUALLY TRANSMITTED DISEASE; TEMPERATURE; THERMAL ANALYSIS;

ANIMALS; BIOPHYSICAL PHENOMENA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CIRCULAR DICHROISM; DISEASE MODELS, ANIMAL; HYDROGEN-ION CONCENTRATION; MICE; MULTIPROTEIN COMPLEXES; PNEUMONIA, BACTERIAL; PORINS; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

EID: 70350068542     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900110q     Document Type: Conference Paper

References (33)

1. Adler, M. W. Sexual health - health of the nation. Sex. Transm. Infect. 2003, 79 (2), 85-87
2. LaMontagne, D. S.; Fine, D. N.; Marrazzo, J. M. Chlamydia trachomatis infection in asymptomatic men. Am. J. Prev. Med. 2003, 24 (1), 36-42.
3. Miller, W. C.; Ford, C. A.; Morris, M.; Handcock, M. S.; Schmitz, J. L.; Hobbs, M. M.; Cohen, M. S.; Harris, K. M.; Udry, J. R. Prevalence of chlamydial and gonococcal infections among young adults in the United States. J. Am. Med. Assoc. 2004, 291 (18), 2229-2236 (Pubitemid 38608172)
4. Westrom, L.; Joesoef, R.; Reynolds, G.; Hagdu, A.; Thompson, S. E. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex. Transm. Dis. 1992, 19 (4), 185-192
5. Polack, S.; Brooker, S.; Kuper, H.; Mariotti, S.; Mabey, D.; Foster, A. Mapping the global distribution of trachoma. Bull. World Health Org. 2005, 83 (12), 913-919
6. Grayston, J. T.; Wang, S. P. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex. Transm. Dis. 1978, 5 (2), 73-77
7. Stephens, R. S.; Sanchez-Pescador, R.; Wagar, E. A.; Inouye, C.; Urdea, M. S. Diversity of Chlamydia trachomatis major outer membrane protein genes. J. Bacteriol. 1987, 169 (9), 3879-3885
8. Fitch, W. M.; Peterson, E. M.; de la Maza, L. M. Phylogenetic analysis of the outer-membrane-protein genes of Chlamydiae, and its implication for vaccine development. Mol. Biol. Evol. 1993, 10 (4), 892-913. (Pubitemid 23204802)
9. Wang, S. P.; Grayston, J. T. Classification of trachoma virus strains by protection of mice from toxic death. J. Immunol. 1963, 90, 849-856
10. Pal, S.; Peterson, E. M.; de la Maza, L. M. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect. Immun. 2005, 73 (12), 8153-8160
11. Sun, G.; Pal, S.; Sarcon, A. K.; Kim, S.; Sugawara, E.; Nikaido, H.; Cocco, M. J.; Peterson, E. M.; de la Maza, L. M. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J. Bacteriol. 2007, 189 (17), 6222-6235 (Pubitemid 47378629)
12. Brunham, R. C.; Zhang, D. J.; Yang, X.; McClarty, G. M. The potential for vaccine development against chlamydial infection and disease. J. Infect. Dis. 2000, 181 (Suppl 3:S), S538-43.
13. Stephens, R. S. Chlamydial genomics and vaccine antigen discovery. J. Infect. Dis. 2000, 181 (Suppl. 3:S), 521-523
14. Batteiger, B. E.; Rank, R. G.; Bavoil, P. M.; Soderberg, L. S. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J. Gen. Microbiol. 1993, 139 (12), 2965-2972 (Pubitemid 2029477)
15. Fan, H.; Li, H.; Zhang, M.; Middaugh, C. R. Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1. J. Pharm. Sci. 2007, 96 (6), 1490-1503
16. Nonoyama, A.; Laurence, J. S.; Garriques, L.; Qi, H.; Le, T.; Middaugh, C. R. A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams. J. Pharm. Sci. 2008, 97 (7), 2552-2567
17. Caldwell, H. D.; Kromhout, J.; Schachter, J. Purification and characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 1981, 31, 1161-1176 (Pubitemid 11155484)
18. Yen, T.-Y.; Pal, S.; de la Maza, L. M. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Biochemistry 2005, 44 (16), 6250-6256
19. Kueltzo, L. A.; Ersoy, B.; Ralston, J. P.; Middaugh, C. R. Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. J. Pharm. Sci. 2003, 92 (9), 1805-1820
20. Markham, A. P.; Birket, S. E.; Picking, W. D.; Picking, W. L.; Middaugh, C. R. pH sensitivity of type III secretion system tip proteins. Proteins 2008, 71 (4), 1830-1842
21. Harn, N.; Allan, C.; Oliver, C.; Middaugh, C. R. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability. J. Pharm. Sci. 2007, 96 (3), 532-546
22. Ausar, S. F.; Espina, M.; Brock, J.; Thyagarayapuran, N.; Repetto, R.; Khandke, L.; Middaugh, C. R. High-throughput screening of stabilizers for respiratory syncytial virus: identification of stabilizers and their effects on the conformational thermostability of viral particles. Hum. Vaccines 2007, 3 (3), 94-103.
23. Peek, L. J.; Brandau, D. T.; Jones, L. S.; Joshi, S. B.; Middaugh, C. R. A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. Vaccine 2006, 24 (31-32), 5839-5851
24. Salnikova, M. S.; Joshi, S. B.; Rytting, J. H.; Warny, M.; Middaugh, C. R. Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability. J. Pharm. Sci. 2008, 97 (9), 3735-3752
25. Markovic-Housley, Z.; Garavito, R. Effect of temperature and low pH on structure and stability of matrix porin in micellar detergent solutions. Biochim. Biophys. Acta 1985, 869 (2), 158-170
26. Shang, E.; Exner, M.; Summers, T.; Martinich, C.; Champion, C.; Hancock, R.; Haake, D. The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect. Immun. 1995, 63 (8), 3174-3181
27. Kamerzell, T. J.; Unruh, J. R.; Johnson, C. K.; Middaugh, C. R. Conformational flexibility, hydration and state parameter fluctuations of fibroblast growth factor-10: effects of ligand binding. Biochemistry 2006, 45 (51), 15288-15300
28. Fan, H.; Vitharana, S. N.; Chen, T.; O'Keefe, D.; Middaugh, C. R. Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20. Mol. Pharmaceutics 2007, 4 (2), 232-240 (Pubitemid 46640599)
29. Mach, H.; Ryan, J.; Burke, C.; Volkin, D.; Middaugh, C. Partially structured self-associating states of acidic fibroblast growth factor. Biochemistry 1993, 32 (30), 7703-7711 (Pubitemid 23240815)
30. Lee, J.; Timasheff, S. The stabilization of proteins by sucrose. J. Biol. Chem. 1981, 256 (14), 7193-7201
31. Shimizu, S.; Smith, D. J. Preferential hydration and the exclusion of cosolvents from protein surfaces. J. Chem. Phys. 2004, 121 (2), 1148-1154
32. Uedaira, H.; Uedaira, H. Role of hydration of polyhydroxy compounds in biological systems. Cell. Mol. Biol. (Noisy-le-grand) 2001, 47 (5), 823-829
33. Wang, Y. J. Parenteral Products pf Peptides and Proteins. In Pharmaceutical Dosage Forms: Parenteral Medications, 2nd ed.; Avis, K. E., Lieberman, H. A., Lachman, L., Eds.; Marcel Dekker Inc.: New York, 1992; Vol.1, pp 283-319.